{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:01:01Z","timestamp":1773792061356,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.urolonc.2008.04.002","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T04:33:58Z","timestamp":1230266038000},"page":"64-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)"],"prefix":"10.1016","volume":"27","author":[{"given":"Stacy","family":"Loeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara N.","family":"Gashti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Catalona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2008.04.002_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.urology.2005.08.040","article-title":"Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old","volume":"67","author":"Loeb","year":"2006","journal-title":"Urology"},{"issue":"16","key":"10.1016\/j.urolonc.2008.04.002_bib2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.1992.03480160073037","article-title":"Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease","volume":"267","author":"Carter","year":"1992","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.urolonc.2008.04.002_bib3","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.juro.2007.08.016","article-title":"Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng\/ml","volume":"178","author":"Loeb","year":"2007","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2008.04.002_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.juro.2006.09.063","article-title":"Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening","volume":"177","author":"Moul","year":"2007","journal-title":"J Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.urolonc.2008.04.002_bib5","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1097\/01.ju.0000127736.86597.e7","article-title":"Variation in prostate specific antigen results from two different assay platforms: Clinical impact on 2,304 patients undergoing prostate cancer screening","volume":"171","author":"Link","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2008.04.002_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0090-4295(99)80383-5","article-title":"Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population","volume":"47","author":"Roehrborn","year":"1996","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2008.04.002_bib7","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0022-5347(01)64708-6","article-title":"Biological variation of total, free, and percent free serum prostate specific antigen levels in screening volunteers","volume":"157","author":"Ornstein","year":"1997","journal-title":"J Urol"},{"issue":"20","key":"10.1016\/j.urolonc.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1001\/jama.289.20.2695","article-title":"Variation of serum prostate-specific antigen levels: An evaluation of year-to-year fluctuations","volume":"289","author":"Eastham","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.urolonc.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0090-4295(89)90131-3","article-title":"Elevated serum prostate-specific antigen due to acute bacterial prostatitis","volume":"33","author":"Dalton","year":"1989","journal-title":"Urology"},{"issue":"2 Pt 1","key":"10.1016\/j.urolonc.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","article-title":"Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels","volume":"154","author":"Nadler","year":"1995","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2008.04.002_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.urology.2007.06.1102","article-title":"Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients","volume":"70","author":"Kandirali","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2008.04.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2007.12.008","article-title":"The relationship of PSA velocity to histologic findings in a prostate cancer screening program","author":"Eggener","year":"2008","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2008.04.002_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.ju.0000162017.24965.2b","article-title":"Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen","volume":"174","author":"Schaeffer","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.04.002_bib14","unstructured":"Serretta V, Catanese A, Daricello G, et al. PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients. Prostate Cancer Prostatic Dis [Epub ahead of print 17 July 2007]."},{"issue":"4","key":"10.1016\/j.urolonc.2008.04.002_bib15","first-page":"3653","article-title":"Extended-spectrum \u03b2-lactamase gram-negative sepsis following prostate biopsy: Implications for use of fluoroquinolone prophylaxis","volume":"14","author":"Cannon","year":"2007","journal-title":"Can J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:55:00Z","timestamp":1761040500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143908000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1078143908000768"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.04.002","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}